MAGEA3 and metastatic melanoma: Treatment of metastatic melanoma patients with TCR-T cells targeting MART-1 and MAGE-A3 resulted in fatal cardiotoxicity, perhaps because MART-1 and MAGE-A3 are highly expressed in heart tissue (23, 24).